EGFR and Alzheimer disease: The generated results demonstrated that five genes were significant in the AD sample; four of them (CHMP2A, EGFR, MDH1, and PKN2) exhibited differences (p < 0.05) in cross-platform expression level in AD tissues, while HSP90B1 showed alterations in independent dataset GSE5281.